SAMA Schultze Special Purpose Acquisition

Clever Leaves to Ring the NASDAQ Closing Bell today, December 21st at 3:45pm EST

Clever Leaves to Ring the NASDAQ Closing Bell today, December 21st at 3:45pm EST

NEW YORK, Dec. 21, 2020 (GLOBE NEWSWIRE) -- Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a leading multi-national operator and licensed producer of pharmaceutical-grade cannabinoids, announced that Chief Executive Officer, Kyle Detwiler, and other members of the management team, will ring the Nasdaq Closing Bell remotely from across its various global offices today.

The Clever Leaves closing bell ceremony will be broadcast live starting at 3:45pm Eastern Time at . The Company is newly listed and its securities began trading on Nasdaq on December 18, 2020 following the completion of its business combination with Schultze Special Purpose Acquisition Corp. (“SAMA”).

“Today is a momentous day and a great honor to be one of the few Nasdaq-listed cannabis companies. We are proud of what we have accomplished to date in achieving an industry-leading position through our high-quality EU GMP certified operations and scalable cultivation and extraction capacity. Our business combination with SAMA and listing on Nasdaq present a great opportunity to accelerate the commercialization of our high-quality products as well as expand our operations and distribution in attractive markets around the world. We appreciate the continued dedication of our employees and support from our investors, and are excited to be celebrating this monumental next step with them,” said Kyle Detwiler, CEO of Clever Leaves.

About Clever Leaves International Inc.

Clever Leaves is a multi-national cannabis company with a mission to operate in compliance with federal and state laws and with an emphasis on ecologically sustainable, large-scale cultivation and pharmaceutical-grade processing as the cornerstones of its global cannabis business. With operations and investments in the United States, Canada, Colombia, Germany and Portugal, Clever Leaves has created an effective distribution network and global footprint, with a foundation built upon capital efficiency and rapid growth. Clever Leaves aims to be one of the industry’s leading global cannabis companies recognized for its principles, people, and performance while fostering a healthier global community. For more information, please visit .

Forward Looking Statements

This press release includes forward-looking statements that involve risks and uncertainties. Forward-looking statements are statements that are not historical facts and may be identified by the words “estimates,” “projected,” “expects,” “anticipates,” “forecasts,” “plans,” “intends,” “believes,” “seeks,” “may,” “will,” “should,” “future,” “propose” and variations of these words or similar expressions (or the negative versions of such words or expressions). Such forward-looking statements are subject to risks and uncertainties, which could cause actual results to differ from the forward-looking statements. Factors that may cause such differences include, without limitation, the inability to recognize the anticipated benefits of the Business Combination; the ability to continue to meet Nasdaq’s listing standards following the consummation of the Business Combination; expectations with respect to future operating and financial performance and growth, including if or when Clever Leaves will become profitable; Clever Leaves’ ability to execute its business plans and strategy and to receive regulatory approvals; potential litigation involving the parties; global economic conditions; geopolitical events, natural disasters, acts of God and pandemics, including, but not limited to, the economic and operational disruptions and other effects of COVID-19; regulatory requirements and changes thereto; access to additional financing; and other risks and uncertainties indicated from time to time in filings with the SEC. The foregoing list of factors is not exclusive. Additional information concerning certain of these and other risk factors is contained in the Company’s and SAMA’s most recent filings with the SEC and is contained in the final prospectus and definitive proxy statement, filed with the SEC by the Company and SAMA, respectively, on November 27, 2020. All subsequent written and oral forward-looking statements concerning the Company, SAMA or Clever Leaves International Inc. (“Clever Leaves International”), the transactions described herein or other matters and attributable to the Company, SAMA, Clever Leaves International or any person acting on their behalf are expressly qualified in their entirety by the cautionary statements above. Readers are cautioned not to place undue reliance upon any forward-looking statements, which speak only as of the date made. Each of the Company, SAMA and Clever Leaves International expressly disclaims any obligations or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in their expectations with respect thereto or any change in events, conditions or circumstances on which any statement is based.

Investor Relations

Sean Mansouri, CFA or Cody Slach

Gateway Investor Relations



(949) 574-3860

Media Relations

KCSA Strategic Communications

McKenna Miller



(347) 487-6197 



EN
21/12/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Schultze Special Purpose Acquisition

 PRESS RELEASE

Clever Leaves Announces Voluntary Delisting and SEC Deregistration

Clever Leaves Announces Voluntary Delisting and SEC Deregistration TOCANCIPÁ, Colombia, April 26, 2024 (GLOBE NEWSWIRE) -- Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a global medicinal cannabis company, today announced that its Board of Directors (the “Board”) determined to voluntarily delist its common shares, without par value (the “common shares”) and warrants, each exercisable for 1/30th common share at an exercise price of $11.50 (the “Warrants” and together with the common shares, the “Securities”) from The Nasdaq Stock Market LLC (“Nasdaq”...

 PRESS RELEASE

Clever Leaves Reports Fourth Quarter and Full Year 2023 Results

Clever Leaves Reports Fourth Quarter and Full Year 2023 Results - 2023 Revenue Increased 6% Year-Over-Year, with a 39% Increase in Full-Year Cannabinoid Revenue - - Drove Year-over-Year General and Administrative Expense Reductions of 26% in Q4 2023 and 24% for the Full Year - - Completed Sale of Non-Cannabinoid Herbal Brands Business on March 21, 2024 for $8.02 Million, Including $7.02 Million in Cash Paid at Closing - TOCANCIPÁ, Colombia, April 01, 2024 (GLOBE NEWSWIRE) -- Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a global medicinal cannabi...

 PRESS RELEASE

Clever Leaves and Paradise Seeds to Develop and Register Genetic Asset...

Clever Leaves and Paradise Seeds to Develop and Register Genetic Assets in Colombia TOCANCIPÁ, Colombia, Feb. 13, 2024 (GLOBE NEWSWIRE) -- Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a global medicinal cannabis company, announced today that through its partnership with award-winning Dutch seed bank, Paradise Seeds (“Paradise”), to develop and register high performance cannabis cultivars in Colombia, Clever Leaves will have exclusive license to cultivate some of these genetics, while Paradise will make other cultivars available to third parties for...

 PRESS RELEASE

Clever Leaves Granted Australian GMP Certification for Cannabis Produc...

Clever Leaves Granted Australian GMP Certification for Cannabis Products by the Therapeutic Goods Administration (TGA) Multinational operator has been granted Australian GMP certification by the TGA for the manufacturing of cannabis products. Clever Leaves is the first and only medicinal cannabis company globally that has GMP certifications from the European Union, Colombia, Brazil and Australia. TOCANCIPÁ, Colombia, Jan. 03, 2024 (GLOBE NEWSWIRE) -- Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW), a global medicinal cannabis company, announced today that it has been granted Australia...

 PRESS RELEASE

Clever Leaves Reports Third Quarter 2023 Results

Clever Leaves Reports Third Quarter 2023 Results - Q3 Revenue Increased 33% Year-Over-Year, Propelled by 135% Year-Over-Year Growth in Cannabinoid Revenue, Along with 6% Year-Over-Year Growth in Non-Cannabinoid Revenue - - Q3 Adjusted EBITDA Improved Year-Over-Year to $(2.6) Million Compared to $(3.7) Million, Reflecting Revenue Growth and Continued Aggressive Expense Reductions - - Cash Balance at October 31, 2023 was $6.2 Million, with $1.9 Million in Subsequent Capital Received from the November Sale of the Company’s Remaining Stake in Cansativa - - Updated Full Ye...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch